Integrative Therapy for Breast, Colon, Ovarian, Pancreatic and Head/Neck Cancer

Share Button

Evidence-based, Integrative Therapy to Promote Apoptosis, Enhance the Efficacy of Chemo while Reducing Multi-Drug Resistance

Bitter Melon extract (BME) kills breast, colon, ovarian, pancreatic, liver, head and neck, and probably other cancers too. More importantly, Bitter Melon extract enhances the efficacy of certain chemotherapeutic agents. Please refer to the studies linked below.

Since the founding of PeopleBeatingCancer in 2004, it has become increasingly clear to me that toxic therapies lose their efficacy while causing short, long-term and late-stage side effects.

In short, cancer patients need help if they exclusively focus on chemotherapy and/or radiation. Bitter melon extract is just the kind of support that cancer patients need.

Is the information linked and excerpted below “clinical controlled” evidence? No. But the evidence-based research below clearly indicates that Bitter Melon extract may play a significant role in managing your cancer.

I was diagnosed with an “incurable” blood cancer, multiple myeloma, in 1994. Aggressive conventional therapies did little for me. I have been living in complete remission from my incurable cancer since April of 1999 by living an evidence-based, non-toxic, anti-cancer lifestyle through nutrition, supplementation, bone health, detoxification, and more.

I am both a cancer survivor and cancer coach. For more information about non-conventional therapies for your cancer scroll down the page, post a question and I will reply ASAP.

Thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Recommended Reading:

Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis.

“BME treatment of breast cancer cells resulted in a significant decrease in cell proliferation and induced apoptotic cell death. Apoptosis of breast cancer cells was accompanied by increased poly(ADP-ribose) polymerase cleavage and caspase activation. Subsequent studies showed that BME treatment of breast cancer cells inhibited survivin and claspin expression..”

Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade

Conclusion. BME functions as a natural AMPK activator in the inhibition of ovarian cancer cell growth and might be useful as a supplement to improve the efficacy of cisplatin-based chemotherapy in ovarian cancer.”

Bitter melon juice prevents pancreatic cancer in mouse models

“A new study shows that bitter melon juice restricts the ability of pancreatic cancer cells to metabolize glucose, thus cutting the cells’ energy source and eventually killing them…”

Momordica charantia lectin exhibits antitumor activity towards hepatocellular carcinoma.

“Our data show that the natural compound MCL manifests antitumor activities towards HCC and therefore suggest MCL as a promising chemotherapeutic agent.”

Bitter melon reduces head and neck squamous cell carcinoma growth by targeting c-Met signaling.

” We also observed that BME treatment in HNSCC reduced phosphoStat3, c-myc and Mcl-1 expression, downstream signaling molecules of c-Met. Furthermore, BME treatment in HNSCC cells modulated the expression of key cell cycle progression molecules leading to halted cell growth…”

Bitter melon extracts enhance the activity of chemotherapeutic agents through the modulation of multiple drug resistance.

“Here, we determined BME effects on anticancer activity and bioavailability of doxorubicin (DOX) in colon cancer cells. BME enhanced the effect of DOX on cell proliferation and sensitized the cells toward DOX upon pretreatment. Furthermore, there was both increased drug uptake and reduced drug efflux. We also observed a reduction in the expression of multidrug resistance conferring proteins (MDRCP) P-glycoprotein, MRP-2, and BCRP…”

Leave a Comment:

Add Your Reply